Organogenesis Holdings (ORGO) Treasury Shares (2016 - 2026)

Organogenesis Holdings' Treasury Shares history runs 11 years deep, the most recent figure standing at $5.6 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 836.7% year-over-year to $5.6 million in Q1 2026; TTM through Mar 2026 was $5.6 million, a 836.7% increase from a year earlier, with the FY2025 full-year figure at $397800.0, down 91.22% from the prior year.
• Treasury Shares grew to $5.6 million in Q1 2026 per ORGO's latest filing, from $130000.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $5.6 million in Q1 2026 and bottomed at $130000.0 in Q4 2024.
• The 5-year median for Treasury Shares is $4.0 million (2023), against an average of $2.9 million.
• Across the five-year window, Treasury Shares plunged 85.89% in 2025 and surged 836.7% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $1.4 million in 2022, then surged by 187.37% to $4.0 million in 2023, then tumbled by 96.73% to $130000.0 in 2024, then changed by 0.0% to $130000.0 in 2025, then jumped by 4242.87% to $5.6 million in 2026.
• Per Business Quant, the three latest ORGO Treasury Shares figures stand at $5.6 million (Q1 2026), $130000.0 (Q4 2025), and $4.8 million (Q3 2025).